FDA Approves Dupixent to Treat Eczema
Active ingredient binds to protein (interleukin-4 receptor alpha subunit) that causes inflammation
Psoriasis May Up Risk of Melanoma, Hematologic Cancer
No differences in risk observed for type of psoriasis therapy, including systemic or biologic medications
ACP Issues Challenge to Cut Task Burden and Put Patients First
American College of Physicians details policy recommendations to reduce administrative burden
TV Ads for ACA Enrollment Linked to Decline in Uninsured Rates
Counties exposed to higher volumes of local insurance ads had larger drop in uninsurance
Advanced Age Need Not Deter Surgery for Cutaneous Tumors
No difference in complications between those aged 90 years and older and those 75 to 80 years
Suicide Risk Not Up With New Rx of 5α-Reductase Inhibitor for BPH
But increased risk of self-harm and depression during initial 18 months after initiation of 5α-reductase
Paid Malpractice Claims Cut in Half From 1992 to 2014 in U.S.
But, increase in mean compensation amounts and percentage of paid claims exceeding $1 million
Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal
Findings based on number of laser passes during a five-minute tattoo removal session
FDA Approves Bavencio for Merkel Cell Carcinoma
Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States
C1 Inhibitor Use Reduces Attacks in Hereditary Angioedema
Subcutaneous CSL830 at doses of 40 and 60 IU reduce rate of attacks, need for rescue medication
